The proportion of HER2-positive cases in papillary adenocarcinoma was higher than in other histological types, consistent with some previous reports claiming that HER2 expression in cholangiocarcinoma is associated with an early disease stage (Endo et al, 2002; Nakazawa et al, 2005). This evidence concerns the gene ERBB2 and cholangiocarcinoma.